Trichomonas vaginalis and the human immunodeficiency virus (HIV): an integrative literature review
Trichomonas vaginalis and the human immunodeficiency virus (HIV): an integrative literature review
DOI:
https://doi.org/10.47456/hb.v6i1.48318Keywords:
human immunodeficiency, sexually transmitted infections, trichomoniasis, HIV.Abstract
Trichomonas vaginalis is the parasite that causes trichomoniasis, a non-viral sexually transmitted infection that is widely prevalent worldwide and mostly affects women. The disease is transmitted mainly through unprotected sexual contact and is asymptomatic in most cases. Given the studies that point to T. vaginalis infection and a greater susceptibility to other sexually transmitted diseases, the aim of this study was to relate this disease to a greater susceptibility to HIV and to present scientific data that can be used to formulate prevention methodologies for both infections. An integrative literature review was carried out, covering the period from 2005 to 2021, based on articles indexed in the SciELO, Pubmed and LILACS databases. The descriptors chosen, according to the classification of health sciences descriptors (DeCS) were: “Trichomonas vaginalis”, ‘HIV’ and “Human Immunodeficiency”, combined in English, Portuguese and Spanish. The searches were conducted based on a guiding question and the articles were selected using pre-defined inclusion and exclusion criteria. Based on the results, it was observed that the main variables related to both infections were: female gender; white and black race/color; being pregnant; single, divorced and widowed marital status; low schooling and income and behavioral variables (multiple sexual partners and alcohol abuse). In relation to the guiding question of the review, it was possible to conclude that the presence of T. vaginalis infection increases the risk of the individual becoming infected with HIV and vice-versa, and that interventions and methodologies aimed at knowledge and prevention of both diseases are necessary.
References
1. AMBROZIO CL, NAGEL AS, JESKE S, BRAGANÇA GCM, BORSUK S, VILLELA MM. Trichomonas vaginalis prevalence and risk factors for women in southern Brazil. Rev. Inst. Med. Trop. São Paulo 58: 245-252, 2016.
2. BOUCHEMAL K, BORIES C, LOISEAU PM. Estratégias para prevenção e tratamento de infecções por Trichomonas vaginalis. Clin. microbiol. rev 30(2): 811-825, 2017.
3. BRUNI MP, SANTOS CC, STAUFFERT D, FILHO NC, BICCA GO, SILVEIRA MF, FARIAS NAR. Trichomonas vaginalis and HIV infection: relation and prevalence among women in southern Brazil. JTP 48(1): 15-24, 2019.
4. CARDOSO LRD, MALBERGIER A, FIGUEIREDO TFB. O consumo de álcool como fator de risco para a transmissão das DSTs/HIV/Aids. Arch. Clin. Psychiatry (Impr.) 35(3): 70-75, 2008.
5. CARVALHO NS, JÚNIOR JE, TRAVASSOS AG, SANTANA LB MIRANDA AE. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecções que causam corrimento vaginal. Epidemiol. serv. saúde 30(1): 1-12, 2021.
6. CUDMORE SL, GARBER GE. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine. J Inf Pub Health 3(2): 47-53, 2010.
7. EUZÉBIO R. A infecção pelo Trichomonas vaginalis e suas possíveis relações com a aquisição e transmissão do vírus HIV. Rev Cient Faculdade Unimed 2(1): 96-111, 2020.
8. FREITAS L, MAIA LRS, DEUS MRAR, OLIVEIRA SR, PERES AL. Frequency of microorganisms in vaginal discharges of high-risk pregnant women from a hospital in Caruaru, Pernambuco, Brazil. J. bras. patol. med. lab 56: 1-6, 2020.
9. GATTI FAA, CEOLAN E, GRECO FSR, SANTOS PC, KLAFKE GB, OLIVEIRA GR, VON GROLL A, MARTINEZ AMB, GONÇALVES CV, SCAINI CJ. Prevalência de tricomoníase e fatores associados em mulheres atendidas em um hospital universitário no sul do Brasil. Plos One 12(3): 1-11, 2017.
10. HIRT RP. Trichomonas vaginalis virulence factors: an integrative overview. Sex. transm. infect 89(6): 439-443, 2013.
11. LIMA MCL, ALBUQUERQUE TV, BARRETO NETO AC, REHN VNC. Prevalência e fatores de risco independentes à tricomoníase em mulheres assistidas na atenção básica. Acta paul. enferm 26(4): 331-337, 2013.
12. MACIEL G, TASCA T, CARLI GA. Aspectos clínicos, patogênese e diagnóstico de Trichomonas vaginalis. J. bras. patol. med. lab 40(3): 152-160, 2004.
13. MARTINS TA, BELLO PY, BELLO MD, PONTES LRSK, COSTA LV, MIRALLES IS, QUEIROZ TRBS. As doenças sexualmente transmissíveis são problemas entre gestantes no Ceará? J. bras. doenças sex. transm 16(3): 50-58, 2004.
14. MASON PR, FIORI PL, CAPPUCCINELLI P, RAPPELLI P, GREGSON S. Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection. Epidemiol. infect 133(2): 315-323, 2005.
15. MENESES MO, VIEIRA BDG, QUEIROZ ABA, ALVES VH, RODRIGUES DP, SILVA JCS. O perfil do comportamento sexual de risco de mulheres soropositivas para sífilis. Rev. enferm. UFPE on line 11(4): 1584-1594, 2017.
16. MIRANDA AE, PINTO VM, GAYDOS CA. Trichomonas vaginalis infection among young pregnant women in Brazil. Braz. j. infect. dis 18(6): 669-671, 2014.
17. MIRANDA AE, RIBEIRO D, REZENDE EF, PEREIRA GFM, PINTO VM, SARACENI V. Associação de conhecimento sobre DST e grau de escolaridade entre conscritos em alistamento ao Exército Brasileiro. Ciênc. Saúde Colet 18(2): 489-497, 2013.
18. NEVES RG WENDT A, FLORES TR, COSTA CS, COSTA FS, TOVO-RODRIGUES L, NUNES BP, NEVES RG, WENDT A, FLORES TR. Simultaneidade de comportamentos de risco para infecções sexualmente transmissíveis em adolescentes brasileiros, 2012. Epidemiol. serv. saúde 26(3): 443-454, 2017.
19. ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE/ORGANIZAÇÃO MUNDIAL DE SAÚDE. OPAS/OMS. A cada dia, há 1 milhão de novos casos de infecções sexualmente transmissíveis curáveis. 2019. Disponível em: https://www.paho.org/bra/index.php?option=com_content&view=article&id=5958:a-cada-dia-ha-1-milhao-de-novos-casos-de-infeccoes-sexualmente-transmissiveis-curaveis&Itemid=812. Acesso em 21 de outubro de 2020.
20. PARKER R, CAMARGO JUNIOR KR. Pobreza e HIV/AIDS: aspectos antropológicos e sociológicos. Cad. saúde pública 16(1): 89-102, 2000.
21. QUINLIVAN EB, PATEL SN, GRODENSKY CA, GOLIN CE, TIEN HC, HOBBS MM. Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex. transm. dis 39(9): 671-677, 2012.
22. SALAWU, O. T.; ESUME, C. N. Frequency of Human Immunodeficiency Virus (HIV) in Trichomonas vaginalis Infected Women in Badagry, Lagos, Nigeria. JRI 17(1): 61-63, 2016.
23. SILVA LCF, MIRANDA AE, BATALHA RS, MONTE RL, TALHARI S. Trichomonas vaginalis and associated factors among women living with HIV/AIDS in Amazonas, Brazil. Braz. j. infect. dis 17(6): 701-703, 2013.
24. SOUZA MT, SILVA MD, CARVALHO R. Integrative review: what is it? How to do it? Einstein (São Paulo) 8(1): 102-106, 2010.
25. TORRES FILHO HM, LEITE CCF. Doenças sexualmente transmissíveis curáveis: diagnóstico laboratorial. J. bras. med 103(1): 17-24, 2015.
26. WAAIJ DJ, DUBBINK JH, OUBURG S, PETERS RPH, MORRÉ SA. Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study. BMJ Open 7(10):e016959, 2017.
27. ZORATI GC, MELLO SA. Incidência da tricomoníase em mulheres atendidas pelo sistema único de saúde em Cascavel e no oeste do Paraná. Arq. ciências saúde UNIPAR 13(2): 136-138, 2009.
Downloads
Published
Issue
Section
License
All works published in the Brazilian Journal of Production Engineering (BJPE) are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0).
This means that:
Anyone can copy, distribute, display, adapt, remix, and even commercially use the content published in the journal;
Provided that due credit is given to the authors and to BJPE as the original source;
No additional permission is required for reuse, as long as the license terms are respected.
This policy complies with the principles of open access, promoting the broad dissemination of scientific knowledge.
🔗 Click here to access the full license
